opportunities available to pharmaceutical firms confronted with the loss of patent protection on their branded drug. The marketing … dimensions of product innovation, pricing and brand equity options are considered together with exclusivity options available … manner to extend the market advantages and earnings levels of the original pharmaceutical compound innovation. Areas of …

innovation with timely generic market entry. An examination of the inefficiencies created by the Canadian regulations reveals … action that evaluates patent validity. An economic incentive to challenge weak patents should also be introduced in Canada …

Settlements of drug patent disputes that involve a potential payment from the brand to the generic signal a possible …

We examine the impact of loss of U.S. patent exclusivity (LOE) on the prices and utilization of specialty drugs between …

, off-patent and generic drug prices are at least four times higher in the United States than in comparable English …-speaking high income countries. With five or more competitors, off-patent drug prices are similar or lower. Our analysis shows that …

prices to maximize their expected total discounted profits. Moreover, generic firms make their entry decisions before patent …